TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34578900

Group type: EXPERIMENTAL
Intervention: High Protein (HP) toddler milk formula (30 g protein, 10 g fat)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Low Protein (LP) toddler milk formula (7 g protein, 20 g fat)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: High Protein (HP) toddler milk formula
Number of subjects: 27

Group type: COMPARATOR
Intervention: Low Protein (LP) toddler milk formula
Number of subjects: 27
Study: 35968550

Group type: EXPERIMENTAL
Intervention: Rosa roxburghii Tratt juice (RRTJ)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 33023997

Group type: EXPERIMENTAL
Intervention: Respiratory therapist‐driven oxygen titration after an electronic alert
Number of subjects: 195

Group type: COMPARATOR
Intervention: Standard of care (titration based on physician order)
Number of subjects: 195
Study: 33408009

Group type: EXPERIMENTAL
Intervention: IV1 (single intravenous dose of 15 mg TXA/kg prior to skin incision)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: IV2 (two intravenous doses of 15 mg TXA/kg: one prior to skin incision and one 6 hours after)
Number of subjects: 400

Group type: COMPARATOR
Intervention: TOP (2 g TXA in 50 ml of saline irrigated topically at the end of surgery)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: COMB (combined IV1 and TOP regimens)
Number of subjects: 400

Group type: COMPARATOR
Intervention: IV1, IV2, COMB
Number of subjects: 400

Group type: COMPARATOR
Intervention: IV1, IV2, COMB, TOP
Number of subjects: 400
Study: 36123259

Group type: EXPERIMENTAL
Intervention: 20 IU/kg Omtv + vaccine
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 40 IU/kg Omtv + vaccine
Number of subjects: 240

Group type: COMPARATOR
Intervention: 20 IU/kg HRIG + vaccine
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo + vaccine
Number of subjects: 240
Study: 32867758

Group type: EXPERIMENTAL
Intervention: Smartphone instruction using an application
Number of subjects: 53

Group type: COMPARATOR
Intervention: Traditional lecture-based instruction
Number of subjects: 53
Study: 33571687

Group type: EXPERIMENTAL
Intervention: Peer recruitment
Number of subjects: 1487

Group type: COMPARATOR
Intervention: Facebook Ads
Number of subjects: 1487

Group type: COMPARATOR
Intervention: ResearchMatch
Number of subjects: 1487
Study: 32703293

Group type: EXPERIMENTAL
Intervention: Communities for Healthy Living (CHL) intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Process evaluation methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Qualitative and quantitative data integration
Number of subjects: 0
Study: 35604745

Group type: EXPERIMENTAL
Intervention: Marriage checkup (active treatment)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 244
Study: 33849953

Group type: EXPERIMENTAL
Intervention: DiaSorin Liaison antigen test
Number of subjects: 414
Study: 34863354

Group type: EXPERIMENTAL
Intervention: Guided internet‐based intervention
Number of subjects: 0
Study: 32871923

Group type: EXPERIMENTAL
Intervention: Hudi enteric-coated capsules (HEC)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Enteric-coated mesalazine tablets placebo
Number of subjects: 240
Study: 34981201

Group type: EXPERIMENTAL
Intervention: Low-load training with BFR
Number of subjects: 27

Group type: COMPARATOR
Intervention: Traditional training
Number of subjects: 27
Study: 34610821

Group type: EXPERIMENTAL
Intervention: Educational intervention based on Pender's health promotion model
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study: 33557762

Group type: EXPERIMENTAL
Intervention: Individualized protocol (IP) group - individualized rescue morphine dosing based on fentanyl test results (10 μg/kg if positive, 50 μg/kg if negative)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Conservative protocol (CP) group - fixed rescue morphine dosing (25 μg/kg)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Individualized protocol (IP) group
Number of subjects: 280
Study: 33119047

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (cholecalciferol), 2000 IU per day
Number of subjects: 25871

Group type: EXPERIMENTAL
Intervention: ω-3 fatty acids, 1 g per day
Number of subjects: 25871

Group type: COMPARATOR
Intervention: Placebo (control group for Vitamin D3)
Number of subjects: 25871

Group type: COMPARATOR
Intervention: Placebo (control group for ω-3 fatty acids)
Number of subjects: 25871

Group type: EXPERIMENTAL
Intervention: Vitamin D3
Number of subjects: 25871

Group type: EXPERIMENTAL
Intervention: ω-3 fatty acids
Number of subjects: 25871
Study: 36028171

Group type: EXPERIMENTAL
Intervention: Er, Yag laser
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Chitosan
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: RB (Rose Bengal)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Autoclave
Number of subjects: 50

Group type: COMPARATOR
Intervention: Chlorhexidine (CHX)
Number of subjects: 50
Study: 34461383

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training associated with transcutaneous tibial nerve stimulation (TTNS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Pelvic floor muscle training isolated
Number of subjects: 24
Study: 616506959

Group type: EXPERIMENTAL
Intervention: Current NFP
Number of subjects: 213

Group type: COMPARATOR
Intervention: Modified NFP (FDA proposals)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Current NFP and modified NFP
Number of subjects: 213

Group type: COMPARATOR
Intervention: Modified NFP formats
Number of subjects: 213
Study: 35131155

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM) (24/7)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Self-Monitored Blood Glucose (BGM) (4 times daily)
Number of subjects: 114
Study: 34054830

Group type: EXPERIMENTAL
Intervention: IL‐26 levels in SLE patients
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: IL‐26 levels in patients with active disease
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Correlation of IL‐26 levels with SLEDAI score
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: High IL‐26 levels
Number of subjects: 109

Group type: COMPARATOR
Intervention: IL‐26 performance compared to classical markers
Number of subjects: 109
Study: 33035075

Group type: EXPERIMENTAL
Intervention: Isometric-resistance exercise program
Number of subjects: 15

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 15
Study: 35258101

Group type: EXPERIMENTAL
Intervention: Vericiguat 2.5 mg (up-titrated to 5 mg and 10 mg) + nitroglycerin 0.4 mg sublingual
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo + nitroglycerin 0.4 mg sublingual
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Vericiguat + nitroglycerin
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo + nitroglycerin
Number of subjects: 36
Study: 33115353

Group type: EXPERIMENTAL
Intervention: QuickDASH questionnaire
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Age group 70-79 and 80-89
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Females aged 50-59
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Motion pain or tenderness at the shoulder and side pinch strength
Number of subjects: 381
Study: 34385148

Group type: EXPERIMENTAL
Intervention: TIME program (intervention)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: CHW knowledge improvement
Number of subjects: 55
Study: 33019392

Group type: EXPERIMENTAL
Intervention: Gestational diabetes mellitus (GDM)
Number of subjects: 50
Study: 35377734

Group type: EXPERIMENTAL
Intervention: Peer comparison report via e-mail displaying individual hospice utilization metrics compared with top-performing peers
Number of subjects: 47

Group type: COMPARATOR
Intervention: Usual care (no report)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Peer comparison report via e-mail
Number of subjects: 47
Study: 34288357

Group type: EXPERIMENTAL
Intervention: 2NRTI + raltegravir
Number of subjects: 48

Group type: COMPARATOR
Intervention: 2NRTI + EFV + losartan
Number of subjects: 48

Group type: COMPARATOR
Intervention: 2NRTI + EFV
Number of subjects: 48

Group type: COMPARATOR
Intervention: 2NRTI + raltegravir + losartan
Number of subjects: 48
Study: 35780177

Group type: EXPERIMENTAL
Intervention: Cold plasma treatment combined with pyroligneous acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cold plasma treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Seed plasma treatment combined with biochar application
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adding azolla compost
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Seed plasma treatment with biochar
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plasma and azolla compost
Number of subjects: 0
Study: 33516285

Group type: EXPERIMENTAL
Intervention: Lumacaftor 200 mg–ivacaftor 250 mg orally once every 12 h for up to 120 weeks
Number of subjects: 239

Group type: COMPARATOR
Intervention: Lumacaftor–ivacaftor therapy
Number of subjects: 239
Study: 35285923

Group type: EXPERIMENTAL
Intervention: Therapist-guided ICBT
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Unguided ICBT
Number of subjects: 120

Group type: COMPARATOR
Intervention: Face-to-face CBT
Number of subjects: 120
Study: 32134686

Group type: EXPERIMENTAL
Intervention: FHIR-based computational pipeline for electronic data capture (EDC)
Number of subjects: 287
Study: 37563643

Group type: EXPERIMENTAL
Intervention: Re-pigmentation scores (RPS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitiligo noticeability scale (VNS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitiligo specific quality of life instrument (VitiQoL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Total VitiQoL score
Number of subjects: 0
Study: 33539147

Group type: EXPERIMENTAL
Intervention: Restorative intervention
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Combined Restorative and Compensatory intervention
Number of subjects: 4

Group type: COMPARATOR
Intervention: Active Control
Number of subjects: 4
Study: 33238946

Group type: EXPERIMENTAL
Intervention: Unconditional cash transfers combined with mobile application on nutrition counselling
Number of subjects: 0
Study: 33295267

Group type: EXPERIMENTAL
Intervention: Rehabilitation with destabilisation devices
Number of subjects: 26

Group type: COMPARATOR
Intervention: Rehabilitation without destabilisation devices
Number of subjects: 26
Study: 35109566

Group type: EXPERIMENTAL
Intervention: CoCO health education program (8-week, 2-hours per week)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Wait-list control group (received CoCO manual)
Number of subjects: 14
Study: 32859250

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with oral medication
Number of subjects: 0

Group type: COMPARATOR
Intervention: Western medicine treatment plan
Number of subjects: 0
Study: 34376972

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (1.0 mg/kg bolus, 1.0 mg/kg/h until end of surgery)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 60
Study: 35085391

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 infection
Number of subjects: 2777768

Group type: COMPARATOR
Intervention: No positive tests (control)
Number of subjects: 2777768
Study: 34517296

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery with thrombolysis
Number of subjects: 379

Group type: COMPARATOR
Intervention: Standard medical care (control)
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Not applicable (comparison of outcomes)
Number of subjects: 379
Study: 34686461

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 33734989

Group type: EXPERIMENTAL
Intervention: Metacognitive Training (MCT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 50
Study: 36299194

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment (experimental group)
Number of subjects: 24

Group type: COMPARATOR
Intervention: No antibiotic treatment (control group)
Number of subjects: 24
Study: 35024850

Group type: EXPERIMENTAL
Intervention: After-school programme delivered by teachers and parents for 50 minutes per week
Number of subjects: 196

Group type: COMPARATOR
Intervention: Control group (no after-school programme)
Number of subjects: 196
Study: 34469858

Group type: EXPERIMENTAL
Intervention: Continuous Diffusion of Oxygen (CDO) dressing (TransCu O2, EO2 Concepts Inc., TX, USA) for 4 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard dressing for 4 weeks
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Continuous Diffusion of Oxygen (CDO) dressing (TransCu O2, EO2 Concepts Inc., TX, USA) for 4 weeks (thyroidectomy subgroup)
Number of subjects: 21
Study: 616927963

Group type: COMPARATOR
Intervention: Evening testing (17:00-18:30 h)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Morning testing (7:00-8:30 h)
Number of subjects: 15
Study: 36005919

Group type: EXPERIMENTAL
Intervention: Dry Cupping Therapy (DCT)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Creatine Supplementation (CS)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Creatine Supplementation + Dry Cupping Therapy (CS+DCT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control
Number of subjects: 12
Study: 34734875

Group type: EXPERIMENTAL
Intervention: Telemedical monitoring through the integrated care program DiabCare Tirol
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standard treatment group (from RCTs)
Number of subjects: 27
Study: 32503390

Group type: EXPERIMENTAL
Intervention: SRP + photoactivation of H2O2 with 940 nm diode laser
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: SRP + 940 nm diode laser
Number of subjects: 38

Group type: COMPARATOR
Intervention: Scaling and root planning (SRP)
Number of subjects: 38
Study: 35027421

Group type: EXPERIMENTAL
Intervention: Corticocortical paired associative stimulation (ccPAS) in conjunction with conventional rehabilitation treatment, 10 interventions, 5 times a week for 2 weeks.
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional rehabilitation treatment with sham stimulation.
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Corticocortical paired associative stimulation (ccPAS) in conjunction with conventional rehabilitation treatment.
Number of subjects: 42
Study: 33798512

Group type: EXPERIMENTAL
Intervention: PediBIRN 4-variable clinical decision rule (CDR) applied by intervention physicians
Number of subjects: 420

Group type: COMPARATOR
Intervention: Control group (standard practice)
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: PediBIRN 4-variable clinical decision rule (CDR)
Number of subjects: 420
Study: 33142485

Group type: EXPERIMENTAL
Intervention: 5 g/kg star anise
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: 0.22 g/kg essential oil
Number of subjects: 384

Group type: COMPARATOR
Intervention: Control
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: 5 g/kg leavings
Number of subjects: 384
Study: 35917822

Group type: EXPERIMENTAL
Intervention: Arsenicum album 30C
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Camphora 1M
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Bryonia alba 30C
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 33675113

Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 19

Group type: COMPARATOR
Intervention: CBT-I
Number of subjects: 19
Study: 32630933

Group type: EXPERIMENTAL
Intervention: Low-driving-voltage liquid crystal device (7.5Vrms driving voltage)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-driving-voltage liquid crystal device
Number of subjects: 0
Study: 34060731

Group type: EXPERIMENTAL
Intervention: Pycnogenol® (150 mg daily in 3 doses of 50 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pycnogenol®
Number of subjects: 60
Study: 33575976

Group type: EXPERIMENTAL
Intervention: Self-assessed Older Americans Resources and Services scale
Number of subjects: 67

Group type: COMPARATOR
Intervention: Research assistant-assessed Older Americans Resources and Services scale
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Self-assessed activities of daily living
Number of subjects: 67

Group type: COMPARATOR
Intervention: Research assistant-assessed activities of daily living
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Self-assessed instrumental activities of daily living
Number of subjects: 67

Group type: COMPARATOR
Intervention: Research assistant-assessed instrumental activities of daily living
Number of subjects: 67
Study: 34893371

Group type: EXPERIMENTAL
Intervention: Topical anesthesia (TA) using an eutectic mixture of lidocaine and prilocaine (EMLA)
Number of subjects: 39

Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 39
Study: 32656729

Group type: EXPERIMENTAL
Intervention: Liraglutide (subcutaneous) 0.6 mg/day to 3.0 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Liraglutide (subcutaneous)
Number of subjects: 30
Study: 32492609

Group type: EXPERIMENTAL
Intervention: Articles published after 2000
Number of subjects: 197

Group type: COMPARATOR
Intervention: Articles published before 2000
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: High impact factor (IF)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Sample size
Number of subjects: 197

Group type: COMPARATOR
Intervention: Publication period
Number of subjects: 197

Group type: COMPARATOR
Intervention: Funding
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: High impact factor (IF) in multivariate analysis
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Reporting quality and IF correlation
Number of subjects: 197
Study: 35683550

Group type: EXPERIMENTAL
Intervention: Withdrawn relative
Number of subjects: 1229

Group type: EXPERIMENTAL
Intervention: Agitated relative
Number of subjects: 1229

Group type: COMPARATOR
Intervention: No relatives (control group)
Number of subjects: 1229
Study: 33870915

Group type: EXPERIMENTAL
Intervention: Flexible visitation (12 hr/d) supported by family education
Number of subjects: 863

Group type: COMPARATOR
Intervention: Usual restricted visitation (median, 1.5 hr/d)
Number of subjects: 863
Study: 33940497

Group type: EXPERIMENTAL
Intervention: Exposure to environmental pollution from the petrochemical complex (PCF)
Number of subjects: 328
Study: 34426840

Group type: EXPERIMENTAL
Intervention: Postoperative surveillance protocols (specific protocols for patients)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Clinical follow-up timing
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Factors influencing surveillance intensity
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Variation in monitoring practices
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Need for further research
Number of subjects: 35
Study: 33866584

Group type: EXPERIMENTAL
Intervention: Cohort 1 (patients alive on discharge from ICU)
Number of subjects: 1373

Group type: EXPERIMENTAL
Intervention: Cohort 2 (patients discharged alive from hospital to home)
Number of subjects: 1373
Study: 36303593

Group type: EXPERIMENTAL
Intervention: NET Device (active treatment)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham treatment (control)
Number of subjects: 100
Study: 32575611

Group type: EXPERIMENTAL
Intervention: Flaxseed lignan extract (50 mg/day secoisolariciresinol diglucoside)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46

Group type: COMPARATOR
Intervention: Both treatments (Flaxseed lignan and Placebo)
Number of subjects: 46
Study: 35502668

Group type: EXPERIMENTAL
Intervention: Oliceridine injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 0
Study: 32753258

Group type: EXPERIMENTAL
Intervention: Information booklet about MRI (n = 95)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo booklet (n = 102)
Number of subjects: 197
Study: 36056703

Group type: EXPERIMENTAL
Intervention: Olive Oil (OO)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Cottonseed Oil (CSO)
Number of subjects: 41
Study: 33831552

Group type: EXPERIMENTAL
Intervention: Exenatide twice a day plus glargine
Number of subjects: 200

Group type: COMPARATOR
Intervention: Aspart 70/30 twice a day
Number of subjects: 200
Study: 34114846

Group type: EXPERIMENTAL
Intervention: Superconducting five-qutrit processor
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Cycle benchmarking on a two-qutrit CSUM gate
Number of subjects: 5
Study: 33734770

Group type: EXPERIMENTAL
Intervention: Narrating positive memories
Number of subjects: 65

Group type: COMPARATOR
Intervention: Writing positive memories
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control conditions (not specified)
Number of subjects: 65
Study: 34861492

Group type: EXPERIMENTAL
Intervention: Latent class analysis (LCA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: X-learner with Random Forest (XL-RF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Causal Forest (CF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other algorithms (K-means, partition around medoids, hierarchical, spectral clustering, model-based recursive partitioning)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All algorithms (except LCA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Removing research biomarkers as partitioning variables
Number of subjects: 0
Study: 32242395

Group type: EXPERIMENTAL
Intervention: Liangxue Jiedu decoction (LJD)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Western Medicine (cetirizine hydrochloride, vitamin C, and vitamin B complex)
Number of subjects: 238
Study: 34807286

Group type: EXPERIMENTAL
Intervention: Synchronous transurethral cystolitholapaxy and TURP
Number of subjects: 100

Group type: COMPARATOR
Intervention: Transurethral cystolitholapaxy plus medical therapy (tamsulosin plus finasteride)
Number of subjects: 100
Study: 32329019

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35098979

Group type: EXPERIMENTAL
Intervention: Multidomain interventions focused on cardiovascular and lifestyle related risk factors
Number of subjects: 4162

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 4162
Study: 34460937

Group type: EXPERIMENTAL
Intervention: Integrated palliative care (IPC)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 160